Suppr超能文献

人类乳腺癌中的雌激素受体。II. 组织化学方法与生化检测之间的相关性。

Estrogen receptors in human breast cancer. II. Correlation between the histochemical method and biochemical assay.

作者信息

Meijer C J, van Marle J, Persijn J P, van Niewenhuizen W, Baak J P, Boon M E, Lindeman J

出版信息

Virchows Arch B Cell Pathol Incl Mol Pathol. 1982;40(1):27-37. doi: 10.1007/BF02932848.

Abstract

The present study defines criteria for determining the presence of estrogen-receptors in human breast carcinomas demonstrated by a histochemical assay using 17 beta-estradiol-carboxy-methyl-oxim-bovine serum albumen-FITC. The criteria were: 1) the percentage of cells showing fluorescence; 2) the intensity of the fluorescence observed, and 3) the percentage of epithelial structures in tissue specimens. Using these predefined criteria in 132 human breast carcinomas as 91.6% agreement was found between the results of the histochemical assay and those of the biochemical Charcoal method. The main causes of disagreement (7 of the 11 cases) were sampling errors between the tissue specimens used for the histochemical and biochemical assay, and an insufficient percentage of epithelial structures (less than 15%) to allow biochemical identification of estrogen receptor activity. In the hands of pathologists with experience of the field of histochemistry this histochemical assay may be the method of choice for the assessment of estrogen receptors.

摘要

本研究定义了通过使用17β-雌二醇-羧甲基-肟-牛血清白蛋白-异硫氰酸荧光素的组织化学测定法来确定人乳腺癌中雌激素受体存在的标准。这些标准为:1)显示荧光的细胞百分比;2)观察到的荧光强度;3)组织标本中上皮结构的百分比。在132例人乳腺癌中使用这些预先定义的标准,发现组织化学测定结果与生化活性炭法结果之间的一致性为91.6%。不一致的主要原因(11例中的7例)是用于组织化学和生化测定的组织标本之间的取样误差,以及上皮结构百分比不足(小于15%),无法进行雌激素受体活性的生化鉴定。在具有组织化学领域经验的病理学家手中,这种组织化学测定法可能是评估雌激素受体的首选方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验